On August 6, 2020, President Donald J. Trump signed an executive order mandating the federal government to buy and give preference to certain "essential" drugs and medical supplies developed and made in the U.S. over those from overseas. The move is expected to plug gaps in the pharmaceutical supply chain that have been exposed by the coronavirus pandemic.